Shorter, simpler breast cancer treatment: where evidence meets practice

Studies show that injection-based delivery of HER2 drugs matches IV infusions in safety and efficacy — while saving time for patients and hospitals alike; even as the benefits of subcutaneous therapy are well established in major hospitals, experts say that access remains uneven across India’s mixed healthcare system.

Source link